Advisors Capital Management’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.85M Buy
288,630
+12,275
+4% +$220K 0.06% 209
2025
Q4
$4.43M Buy
276,355
+380
+0.1% +$5.66K 0.05% 218
2025
Q3
$3.41M Buy
275,975
+912
+0.3% +$10.7K 0.04% 239
2025
Q2
$3.17M Buy
275,063
+36,196
+15% +$429K 0.04% 235
2025
Q1
$3.58M Buy
238,867
+7,718
+3% +$129K 0.06% 214
2024
Q4
$4M Sell
231,149
-1,229
-0.5% -$23.7K 0.06% 209
2024
Q3
$4.31M Sell
232,378
-4,916
-2% -$98.7K 0.07% 202
2024
Q2
$4.82M Buy
237,294
+3,316
+1% +$58.7K 0.08% 186
2024
Q1
$4M Buy
233,978
+7,660
+3% +$120K 0.07% 199
2023
Q4
$4M Sell
226,318
-3,786
-2% -$76.3K 0.08% 196
2023
Q3
$5.53M Sell
230,104
-216
-0.1% -$5.3K 0.14% 145
2023
Q2
$5.36M Buy
230,320
+1,887
+0.8% +$42.7K 0.13% 153
2023
Q1
$5.04M Buy
+228,433
New +$5.35M 0.13% 149
2019
Q4
Sell
-37,016
Closed -$1.73M 318
2019
Q3
$1.73M Buy
37,016
+1,523
+4% +$70.8K 0.09% 172
2019
Q2
$1.86M Buy
35,493
+2,557
+8% +$150K 0.11% 163
2019
Q1
$2.27M Buy
+32,936
New +$2.21M 0.14% 158

Other funds holding CLB